GlassScriptPhysician profile
Lori A Teverbaugh
NPI 1427037209
$1,917.77
in general payments reported to CMS, 2019-2025
20 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $67.26 · 2021: $132 · 2022: $212 · 2023: $445 · 2024: $385 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $658.96 | 2019-2025 | Lo Loestrin Fe, Orilissa, Liletta |
| Sumitomo Pharma America, INC. | $326.47 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $303.88 | 2019-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $110.84 | 2023-2025 | Zurzuvae |
| Pfizer INC. | $91.22 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.40 | 2019-2024 | |
| Hologic Sales and Service, LLC | $73.76 | 2019-2025 | Myosure Tissue Removal Device, Coolseal Generator |
| Organon LLC | $33.98 | 2022-2024 | |
| Kowa Pharmaceuticals America, INC. | $32.55 | 2023 | Seglentis |
| Aspira Women'S Health INC | $30.23 | 2022 | |
| Ethicon US, LLC | $27.76 | 2019 | |
| Davol INC. | $27.44 | 2023 | Arista Ah Flexitip |
| Channel Medsystems, INC. | $19.63 | 2022 | |
| Axonics, INC. | $19.41 | 2023 | Axonics |
| Becton, Dickinson and Company | $18.99 | 2023 | Bd Onclarity |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $16.56 | 2025 | Slynd |
| Urovant Sciences INC | $14.87 | 2022 | |
| Daiichi Sankyo INC. | $12.08 | 2019 | |
| Therapeuticsmd, INC. | $11.50 | 2020 | |
| Merck Sharp & Dohme LLC | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Teverbaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.